Effex, a Belgian startup founded in 2023, is carving a niche in the Analytics industry with its innovative approach to the Statistical Design of Experiments (DOE). Positioned as an end-to-end platform, Effex aims to revolutionize how experiments are planned and analyzed, offering a more efficient alternative to traditional methods.
Rooted in extensive research conducted at KU Leuven’s Biostatistics group, the platform was developed under the guidance of Prof. Peter Goos and Dr. Ir. José Núñez Ares. This research highlighted a unique and cost-efficient approach to DOE, enhancing multi-criteria selection of experimental plans.
Effex differentiates itself from legacy software by embracing a cloud-based, future-proof model, directly addressing today's demand for efficiency. While the company has not yet reported any investments, its compelling proposition promises to drive significant interest from ventures seeking innovation in analytics.